Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Galectin Therapeutic (GALT)

Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,896
  • Shares Outstanding, K 62,762
  • Annual Sales, $ 0 K
  • Annual Income, $ -41,070 K
  • EBIT $ -40 M
  • EBITDA $ -40 M
  • 60-Month Beta 0.69
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 537.18% ( +23.38%)
  • Historical Volatility 69.07%
  • IV Percentile 98%
  • IV Rank 68.05%
  • IV High 775.99% on 07/01/24
  • IV Low 28.42% on 12/18/23
  • Put/Call Vol Ratio 5.95
  • Today's Volume 2,927
  • Volume Avg (30-Day) 4,985
  • Put/Call OI Ratio 1.12
  • Today's Open Interest 122,860
  • Open Int (30-Day) 75,541

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.16
  • Number of Estimates 1
  • High Estimate -0.16
  • Low Estimate -0.16
  • Prior Year -0.16
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7950 +15.33%
on 12/09/24
2.9900 -30.77%
on 11/27/24
-0.8299 (-28.62%)
since 11/13/24
3-Month
1.7950 +15.33%
on 12/09/24
3.1700 -34.70%
on 11/11/24
-0.7999 (-27.87%)
since 09/13/24
52-Week
1.5550 +33.13%
on 12/29/23
4.2684 -51.50%
on 04/12/24
+0.4001 (+23.96%)
since 12/13/23

Most Recent Stories

More News
Galectin Therapeutics Presents Clinical Data on NAVIGATE Trial for Esophageal Varices in MASH Cirrhosis at AASLD 2024

Galectin Therapeutics presents NAVIGATE trial findings on portal hypertension in MASH cirrhosis at AASLD 2024. Results expected December 2024.Quiver AI SummaryGalectin Therapeutics, Inc. has announced...

GALT : 2.0200 (+1.51%)
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

GALT : 2.0200 (+1.51%)
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

GALT : 2.0200 (+1.51%)
Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

GALT : 2.0200 (+1.51%)
Rating the Top 4 Unusually Active Call Options From Thursday’s Trading

The top four unusually active call options in Thursday trading had an average Vol/OI ratio of 52.25. While that’s not very high, each has compelling reasons to buy. Here's why.

JPM : 239.49 (-0.84%)
FTDR : 59.07 (-0.40%)
GALT : 2.0200 (+1.51%)
KKR : 155.51 (-0.15%)
CPRI : 21.04 (-2.64%)
TPR : 62.72 (+2.00%)
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 2.0200 (+1.51%)
GLMD : 2.78 (-1.24%)
VKTX : 46.35 (-3.18%)
ETNB : 7.54 (-3.95%)
IVA : 2.42 (-2.42%)
SGMT : 4.39 (-3.30%)
TERN : 6.55 (-0.61%)
NVO : 105.93 (-2.47%)
IQV : 199.89 (-0.24%)
MDGL : 296.34 (-2.03%)
Galectin Therapeutics Announces $60 Million Credit Line from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through 2024

NORCROSS, Ga., July 26, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...

GALT : 2.0200 (+1.51%)
Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations at the EASL International Liver Congressâ„¢ 2022

NORCROSS, Ga., June 21, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3,...

GALT : 2.0200 (+1.51%)
Galectin Therapeutics to Present in Upcoming H.C. Wainwright Global Investment Conference and the 5th Global NASH Congress

NORCROSS, Ga., May 23, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin...

GALT : 2.0200 (+1.51%)
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update

NORCROSS, Ga., May 16, 2022 (GLOBE NEWSWIRE) --  Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin...

GALT : 2.0200 (+1.51%)

Business Summary

Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring...

See More

Key Turning Points

3rd Resistance Point 2.1633
2nd Resistance Point 2.0967
1st Resistance Point 2.0433
Last Price 2.0200
1st Support Level 1.9233
2nd Support Level 1.8567
3rd Support Level 1.8033

See More

52-Week High 4.2684
Fibonacci 61.8% 3.2319
Fibonacci 50% 2.9117
Fibonacci 38.2% 2.5915
Last Price 2.0200
52-Week Low 1.5550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar